Cogmine Eserine en es it fr

Cogmine Eserine Brand names, Cogmine Eserine Analogs

Cogmine Eserine Brand Names Mixture

  • No information avaliable

Cogmine Eserine Chemical_Formula


Cogmine Eserine RX_link

Cogmine Eserine fda sheet

Cogmine Eserine msds (material safety sheet)

Cogmine Eserine Synthesis Reference

Zhang J,et al. Appl Microbiol Biotechnol. 44(5):568-75.

Cogmine Eserine Molecular Weight

275.346 g/mol

Cogmine Eserine Melting Point

105.5 oC

Cogmine Eserine H2O Solubility

7760 mg/L

Cogmine Eserine State


Cogmine Eserine LogP


Cogmine Eserine Dosage Forms


Cogmine Eserine Indication

For the treatment of glaucoma, and in the treatment of severe anticholinergic toxicity.

Cogmine Eserine Pharmacology

Physostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor which effectively increases the concentration of acetylcholine at the sites of cholinergic transmission. Physostigmine is used to treat glaucoma. Because it crosses the blood-brain barrier, it is also used to treat the central nervous system effects of atropine overdose and other anticholinergic drug overdoses. Physostigmine can reverse both central and peripheral anticholinergia.

Cogmine Eserine Absorption

No information avaliable

Cogmine Eserine side effects and Toxicity

Side effects include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth, blurred vision or change in near or distant vision, and eye pain.

Cogmine Eserine Patient Information

No information avaliable

Cogmine Eserine Organisms Affected

Humans and other mammals